Canada's federal health authority has held a workshop with the drug industry, consumers, doctors and government on whether to allow consumer advertising of prescription drugs.
Health Canada's Health Protection Branch told the meeting that while such advertising has flooded in from the USA, where it has been allowed since 1985, the World Health Organization states that it should not generally be permitted.
The Pharmaceutical Manufacturers' Association of Canada told the workshop that "consumers are no longer content to be part of a paternalistic system of health care," that advertising helps educate consumers and curb improper drug use, and suggested that such advertising could be independently monitored. However, the Canadian Drug Manufacturers Association, which represents the generics makers, noted fears that consumer advertising could increase inappropriate prescribing and thus force health care costs up.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze